Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma
<p>Abstract</p> <p>Background</p> <p>Malignant gliomas recur even after extensive surgery and chemo-radiotherapy. Although a relatively novel chemotherapeutic agent, temozolomide (TMZ), has demonstrated promising activity against recurrent glioma, the effects last only...
Main Authors: | Arai Hajime, Matsuno Akira, Ishii Hisato, Fujimaki Takamitsu, Nakagomi Tadayoshi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-08-01
|
Series: | World Journal of Surgical Oncology |
Online Access: | http://www.wjso.com/content/5/1/89 |
Similar Items
-
Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide
by: Karam Khaddour, et al.
Published: (2020-10-01) -
Acute toxicity of temozolomide for the treatment of anaplastic astrocytoma: A case report
by: Yunni Diansari, et al.
Published: (2021-01-01) -
Complete Radiologic Response in an Anaplastic Oligodendroglioma Treated with Temozolomide and Bevacizumab
by: Artur Katz, et al.
Published: (2009-03-01) -
Temozolomide and cisplatin in relapsed/refractory acute leukemia
by: Rasul Muhammad, et al.
Published: (2009-05-01) -
Bevacizumab and temozolomide in secondary gliomatosis from gemistocytic astrocytoma: a case report
by: Elisa Trevisan, et al.
Published: (2012-06-01)